Viewing nowAtorix Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

MFDS item code 201406140 · Approved 2014.12.30 · Insurance code 669804560
Reduction of the risk of myocardial infarction and stroke and improvement of hyperlipidemia treatment
This medicine helps reduce the risk of cardiovascular diseases. It particularly reduces the risk of cardiovascular events such as myocardial infarction, stroke, vascular interventions, and angina in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. For patients with existing coronary heart disease, it reduces the risk of myocardial infarction, stroke, vascular interventions, hospitalizations for congestive heart failure, and angina. Additionally, it helps patients with hyperlipidemia maintain a healthy lipid profile by reducing total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while increasing HDL cholesterol levels. It is also effective as an adjunct to dietary therapy for familial hypercholesterolemia in children and adolescents, improving dangerous cholesterol levels. Therefore, this medication is used for the prevention of cardiovascular diseases and the treatment of hyperlipidemia.
For hyperlipidemia, the recommended starting dose is 10 mg of atorvastatin once daily; for patients requiring greater LDL cholesterol reduction, it can be initiated at 20 mg or 40 mg once daily. This medication is administered in a dosage range of 10 to 80 mg once daily. After starting treatment and adjusting the dosage, lipid levels should be analyzed within 2 to 4 weeks to adjust the dose. For homozygous familial hypercholesterolemia patients.
For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17), the recommended starting dose is 10 mg once daily, with a maximum dose of 20 mg per day. The dosage should be adjusted according to the therapeutic goal.
This medication may cause serious muscle-related side effects such as myopathy or rhabdomyolysis, so if symptoms like muscle pain or weakness occur, immediately inform your healthcare provider. Do not use this medication in patients with specific liver diseases or serious liver insufficiency; if symptoms of liver dysfunction occur, stop taking the medication and consult a physician. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication and fertile women should use appropriate contraception during treatment. Children under 10 years of age, patients with muscle diseases, and those taking certain medications (e.g., Glecaprevir, Pibrentasvir) should not use this medication. Patients with a history of alcoholism or liver disease, those with impaired kidney function, and elderly patients need to exercise greater caution when using this medication and should consult healthcare providers if muscle pain or abnormal symptoms arise. This medication can interact with various other drugs, so inform your doctor or pharmacist if you are taking any other medications, particularly when taking CYP3A4 inhibitors, cyclosporine, HIV protease inhibitors, and certain antibiotics and antifungals. During treatment with this medication, regular liver function tests and, if necessary, muscle-related tests should be conducted to check for abnormalities. In the case of overdose, there is no specific antidote, and treatment should be symptomatic while closely monitoring liver function and muscle enzyme levels. Finally, this medication should be kept out of reach of children and stored in its original container.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headaches, seizures, confusion, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should ideally be maintained at room temperature between 1 to 30 degrees Celsius. This helps preserve the effectiveness of the medication over time.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.